Related references
Note: Only part of the references are listed.Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium
Eugenia C. Pacheco-Pinedo et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The role of the miR-200 family in epithelial-mesenchymal transition
Perry S. Mongroo et al.
CANCER BIOLOGY & THERAPY (2010)
Loss of miR-200c Expression Induces an Aggressive, Invasive, and Chemoresistant Phenotype in Non-Small Cell Lung Cancer
Paolo Ceppi et al.
MOLECULAR CANCER RESEARCH (2010)
TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
Zhan Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Delta-Crystallin Enhancer Binding Factor 1 Controls the Epithelial to Mesenchymal Transition Phenotype and Resistance to the Epidermal Growth Factor Receptor Inhibitor Erlotinib in Human Head and Neck Squamous Cell Carcinoma Lines
Yasmine Haddad et al.
CLINICAL CANCER RESEARCH (2009)
miR-200 Expression Regulates Epithelial-to-Mesenchymal Transition in Bladder Cancer Cells and Reverses Resistance to Epidermal Growth Factor Receptor Therapy
Liana Adam et al.
CLINICAL CANCER RESEARCH (2009)
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
Don L. Gibbons et al.
GENES & DEVELOPMENT (2009)
Breast tumor heterogeneity: causes and consequences
K. Polyak et al.
BREAST CANCER RESEARCH (2009)
microRNA control of cell-cell signaling during development and disease
Joshua W. Hagen et al.
CELL CYCLE (2008)
Sensitivity to epidermal growth factor receptor inhibitor requires E-cedherin expression in urothelial carcinoma cells
Peter C. Black et al.
CLINICAL CANCER RESEARCH (2008)
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells
Ulrike Burk et al.
EMBO REPORTS (2008)
The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
Sun-Mi Park et al.
GENES & DEVELOPMENT (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?
Witold Filipowicz et al.
NATURE REVIEWS GENETICS (2008)
The role of microRNAs in cancer: No small matter
Erik A. C. Wiemer
EUROPEAN JOURNAL OF CANCER (2007)
Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647
Steven B. Gendreau et al.
CLINICAL CANCER RESEARCH (2007)
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma
Barbara A. Frederick et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Epidermal-growth factor receptor (EGFR) is highly conserved in pancreatic cancer
Ching-Wei D. Tzeng et al.
SURGERY (2007)
Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors
Justin M. Balko et al.
BMC GENOMICS (2006)
Baseline gene expression predicts sensitivity to gefitinib in non-small cell lung cancer cell lines
Christopher D. Coldren et al.
MOLECULAR CANCER RESEARCH (2006)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
RL Yauch et al.
CLINICAL CANCER RESEARCH (2005)
MicroRNA functions in animal development and human disease
I Alvarez-Garcia et al.
DEVELOPMENT (2005)
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition
S Thomson et al.
CANCER RESEARCH (2005)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: Current knowledge and future directions
W Pao et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The MAPPER database: a multi-genome catalog of putative transcription factor binding sites
VD Marinescu et al.
NUCLEIC ACIDS RESEARCH (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
The loss of TGF-β signaling promotes prostate cancer metastasis
WH Tu et al.
NEOPLASIA (2003)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
Share Paper
